文献速递其他结缔组织病

系统性硬化症与局限性硬皮病共存:系统文献综述与观察性队列研究

Coexistence of systemic and localized scleroderma: a systematic literature review and observational cohort study.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

本研究通过系统文献综述和观察性队列研究,描述系统性硬化症(SSc)与局限性硬皮病(LoS)共存的情况。文献综述纳入5项研究,SSc与LoS共存率为2.4%至7.4%;前瞻性队列中296例SSc患者有8例(2.7%)共存LoS。共存病例常见雷诺现象、甲襞视频毛细血管镜(NVC)硬皮病模式及SSc特异性抗体。

要点

  • SSc与LoS共存率在文献中为2.4%至7.4%,队列中为2.7%。
  • 共存病例常见雷诺现象、NVC硬皮病模式和SSc特异性抗体。
  • 本研究首次系统综述并队列评估SSc与LoS共存。

核心结论

  • SSc与LoS存在相对较高的重叠,鉴于两者均为罕见病,这一发现值得关注。

研究设计与样本

  • 系统文献综述遵循PRISMA指南,检索三个电子数据库,最终纳入5项研究进行质量评价和数据提取。
  • 前瞻性队列研究纳入2018年1月至2019年1月在根特大学硬皮病单元进行年度随访的连续SSc患者,共296例。

主要发现

  • 文献综述中SSc与LoS共存率为2.4%至7.4%。
  • 共存病例中常见雷诺现象、NVC硬皮病模式和SSc特异性抗体。
  • 队列中8/296例(2.7%)SSc患者共存LoS;其中6/8有雷诺现象,8/8有NVC硬皮病模式,4/8有SSc特异性抗体(如cenp-B)。

关键数值与推荐

  • 文献综述纳入5项研究,SSc与LoS共存率为2.4%至7.4%。
  • 队列中SSc与LoS共存率为8/296(2.7%)。
  • 共存病例中雷诺现象6/8,NVC硬皮病模式8/8,SSc特异性抗体4/8。

临床怎么用

  • 在SSc患者中应关注LoS共存的可能性,尤其存在雷诺现象、NVC硬皮病模式和SSc特异性抗体时。

局限性

  • 文献综述仅纳入5项研究,队列为单中心前瞻性研究,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: SSc and localized sclerosis (LoS) are considered clinically distinct entities. We describe herein the coexistence of SSc and LoS by both a systematic literature review and an observational cohort study of unselected SSc patients. METHODS: Original studies documenting the coexistence of SSc and LoS were identified in three electronic databases by means of a systematic literature search according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. Additionally, the coexistence of SSc and LoS was studied in a prospective cohort of SSc patients visiting the Ghent University Scleroderma Unit for their yearly follow-up visit between January 2018 and January 2019. RESULTS: Five studies were finally included for quality appraisal and data extraction. The coexistence of SSc and LoS ranged between 2.4 and 7.4%. RP, scleroderma pattern on nailfold videocapillaroscopy (NVC) and the presence of SSc-specific antibodies were commonly observed in coexistent cases. Additionally, coexistence of SSc and LoS was found in 8/296 (2.7%) consecutive SSc patients of the Ghent University Scleroderma Unit. RP was present in 6/8 coexistent cases; a scleroderma pattern on NVC was observed in all coexistent cases, and SSc-specific antibodies (i.e. cenp-B) were found in 4/8 coexistent cases. CONCLUSION: This is the first systematic literature review with additional cohort evaluation investigating the coexistence of SSc and LoS. A relatively high overlap of SSc and LoS was revealed, which is peculiar because both are rare diseases.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Vanhaecke A, De Schepper S, Paolino S, et al. Coexistence of systemic and localized scleroderma: a systematic literature review and observational cohort study. Rheumatology (Oxford). 2020. PMID: 32653905. doi:10.1093/rheumatology/keaa297

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。